Associate Professor, Pathology, New York University School of Medicine

Pathology

Arnaldo Arbini practices Pathology. Doctor Arnaldo A. Arbini, MD is a published doctor. He has 34 papers published. The most current publication "Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII." He is registered with Medicare and accepts Medicare payments.

Publications

---

• Bone marrow uptake of ferumoxytol: A preliminary study in healthy human subjects.
• Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.
• Aromatase deficiency inhibits the permeability transition in mouse liver mitochondria.
• Segmental tandem triplication of the MLL gene in an intravascular large B-cell Lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cy...
• Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
• Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.
• Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.
• Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2.
• A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature.
• Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
• Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants.
• Ischemic stroke in congenital (type II C) defective antithrombin III.
• Angioleiomyoma of the patellar tendon sheath. Case report.
• Mechanism underlying factor VII deficiency in Jewish populations with the Ala244Val mutation.
• Optimal dosing and triggers for prophylactic use of platelet transfusions.
• Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII.
• The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies.
• Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter.
• A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule.
• Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis.
• Effects of hirudin on activated partial thromboplastin time determined with ten different reagents.
• Markers of procoagulant imbalance in patients with localized melanomas and autoimmune Disorders.
• Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio?
• Molecular analysis of Polish patients with factor VII deficiency.
• Determinants of plasma factor VIIa levels in humans.
• Is there an association between ocular adnexal Lymphoma and infection with Chlamydia psittaci? The University of Rochester experience.
• Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.
• Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
• Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literat...
• Unusual presentation of myeloid sarcoma in a case of Acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium.
• Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
• Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma.
• Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regul...

Schools

---

• Universita Degli Studi Di Milano Facolta Di Medicina E Chirurgia

• Maggiore Hospital

• Yale New Haven Hospital

• Cornell University Mc

Conditions Treated

---

• Acute Leukemia
• Chronic Myeloid Leukemia (CML)
• Lymphoma
• Myeloma
• View All

Doctors Specialties

---

• Hematology
• Hematopathology
• Pathology

Accepted Insurances

---

Education

---

• Yale-New Haven Hospital
• Pontifical Xavierian University

Hospital

---

• NYU Langone Medical Center

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1730241712
Last Name Of The Provider	ARBINI
First Name Of The Provider	ARNALDO
View All

Similar Doctors

---

	Dr. Oana Vele, MD This Doctor is OpenDoctor Recommended.
	Dr. John H. McClaskey, MD This Doctor is OpenDoctor Recommended.
	Dr. Tomomi L. Billings, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael B. Broscius, MD This Doctor is OpenDoctor Recommended.
	Dr. Oladapo O. Yeku, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth G. Demicco, MD This Doctor is OpenDoctor Recommended.
	Dr. Isaac A. Bowman, MD This Doctor is OpenDoctor Recommended.
	Dr. Hongbei Wang, MD This Doctor is OpenDoctor Recommended.
	Dr. Kasturi Das, MD This Doctor is OpenDoctor Recommended.
	Dr. Karen B. Larsen, MD
	Dr. Karen B. Carlson, MD
	Dr. Rachel E. Eisenberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Kurt C. Demel, MD This Doctor is OpenDoctor Recommended.
	Dr. Arbaz Samad, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog